SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $9.38 million. The enterprise value is $7.30 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 4.36 million shares outstanding. The number of shares has increased by 389.97% in one year.
| Current Share Class | 4.36M |
| Shares Outstanding | 4.36M |
| Shares Change (YoY) | +389.97% |
| Shares Change (QoQ) | +29.55% |
| Owned by Insiders (%) | 1.85% |
| Owned by Institutions (%) | 10.23% |
| Float | 4.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 91.63 |
| Forward PS | 30.96 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 107.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.54
| Current Ratio | 0.54 |
| Quick Ratio | 0.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -289.37% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $5,667 |
| Profits Per Employee | -$2.47M |
| Employee Count | 12 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.63% in the last 52 weeks. The beta is -1.06, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -1.06 |
| 52-Week Price Change | -7.63% |
| 50-Day Moving Average | 7.24 |
| 200-Day Moving Average | 13.43 |
| Relative Strength Index (RSI) | 42.02 |
| Average Volume (20 Days) | 24,832 |
Short Selling Information
The latest short interest is 288,068, so 6.60% of the outstanding shares have been sold short.
| Short Interest | 288,068 |
| Short Previous Month | 208,825 |
| Short % of Shares Out | 6.60% |
| Short % of Float | 6.73% |
| Short Ratio (days to cover) | 4.33 |
Income Statement
In the last 12 months, ICU had revenue of $68,000 and -$29.67 million in losses. Loss per share was -$10.24.
| Revenue | 68,000 |
| Gross Profit | 68,000 |
| Operating Income | -15.82M |
| Pretax Income | -33.67M |
| Net Income | -29.67M |
| EBITDA | n/a |
| EBIT | -15.82M |
| Loss Per Share | -$10.24 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | 2.08M |
| Total Debt | n/a |
| Net Cash | 2.08M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | -2.05M |
| Book Value Per Share | -0.49 |
| Working Capital | -3.02M |
Full Balance SheetCash Flow
| Operating Cash Flow | -15.80M |
| Capital Expenditures | n/a |
| Free Cash Flow | -15.80M |
| FCF Per Share | -$3.62 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -23,261.76% |
| Pretax Margin | -43,641.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |